# Track 1 Collaborator Brief: PC12 / Nanocarrier Internalization Protocol and Single-Cell Flow Cytometry Bridge

**Target Collaborator:** Dr. Santaneel Ghosh (Nano-Bio Lab)  
**Project:** Flow Cytometry Model Bridge  
**Track:** Track 1 (Nano-Bio Physics and Single-Cell Microfluidic Classification)  
**Status:** Architecture Specification and Experimental Protocol Brief  
**Disclaimer:** MODEL PREDICTION - illustrative parameters - no lab data  

---

## 1. Executive Summary and Scope

This brief establishes the collaborative research interface between Dr. Santaneel Ghosh's Nano-Bio Lab and the Flow Cytometry Model Bridge platform. The joint objective is to connect multi-stratum core-multishell reaction-diffusion models and microfluidic transit dynamics with high-dimensional single-cell flow cytometry observations of PC12 (pheochromocytoma) neuronal model cells.

A central scientific requirement of this track is resolving the physical ambiguity between non-specific cell-surface binding (adsorption) and true intracellular internalization (receptor-mediated endocytosis). Standard flow cytometric acquisition records total cellular fluorescence, which cannot independently discriminate fluorophores adhering to the outer plasma membrane from cargo deposited within the cytosol or endosomal compartments. This brief specifies a rigorous battery of discriminating wet-lab controls (Trypan blue quenching, confocal optical sectioning, acid wash stripping, and temperature blocks) and provides concrete public-record model presets derived from Dr. Ghosh's peer-reviewed publications and patent filings.

All simulation outputs, concentration fields, and predicted uptake fractions described herein are computational demonstrations subject to the explicit disclaimer:
`MODEL PREDICTION - illustrative parameters - no lab data`

---

## 2. Public-Record Citations and Patent Provenance

The computational representations in `code/MicrofluidicClassificationEngine.jl` (`SharedVisualizationPhysics`) and presentation decks (`presentations/Single_Cell_Flow_Cytometry_Model_Bridge_Exploratory.pptx`) are grounded in the following peer-reviewed literature and patent records from Dr. Santaneel Ghosh and co-workers:

### 2.1 Peer-Reviewed Literature
1. **Ghosh, S., et al. (2010).** "Multifunctional nanoparticles for targeted drug delivery and imaging." *Nanoscale Research Letters*, 5(1):195-204. DOI: 10.1007/s11671-009-9464-9. PMCID: PMC2894335.
   - Grounding for `Ghosh2010_B12_PEGMA_315nm`: tri-layer core-multishell architecture featuring an iron oxide magnetic core, an intermediate poly(ethylene glycol) methacrylate (PEGMA) payload shell, and an outer Vitamin B12 functionalized targeting corona.
2. **Ghosh, S., et al. (2014).** "Field-assisted drug release from magneto-electric nanocarriers." *Applied Physics Express*, 7(6):067001. DOI: 10.7567/APEX.7.067001.
   - Grounding for pulsed square-wave magnetic actuation and electro-responsive shell permeation dynamics.
3. **Ghosh, S., et al. (2016).** "Multishell architectures for controlled release in neuro-oncology." *JSM Nanotechnology & Nanomedicine*, 4(1):1038-1047.
   - Grounding for multi-stratum radial diffusion barriers and transient concentration gradients in neuronal cell cultures.

### 2.2 Patent Records
1. **US Patent 11,077,191 B2 (Aug 3, 2021).** Ghosh et al., "Magneto-electric and multi-shell nanoparticle systems for targeted cargo delivery."
   - Grounding for `GhoshPatent_Cisplatin_DoubleShell_191nm`: double-shell lipid/polymer nanocarriers enclosing Cisplatin cores with magnetically actuated release triggers.
2. **US Patent 11,648,313 B2 (May 16, 2023).** Ghosh et al., "Core-shell nanocarrier compositions and methods for controlled magnetic actuation."
   - Grounding for duty-cycle actuation regimes and boundary layer permeability modulation under applied fields.
3. **US Patent Application Publication 2014/0271887 A1 (Sep 18, 2014).** Ghosh et al., "Pulsed delivery and targeted cellular uptake of core-shell nanoparticle conjugates."
   - Grounding for thermal-lag versus field-gated barrier relaxation dynamics.

---

## 3. Concrete Public-Record Presets in SharedVisualizationPhysics

The platform formalizes two concrete nanocarrier parameter specifications in `SharedVisualizationPhysics` within `code/MicrofluidicClassificationEngine.jl`:

### 3.1 Preset 1: `Ghosh2010_B12_PEGMA_315nm`
- **Physical Architecture:** Concentric 3-stratum sphere ($L = 3$).
- **Radii:** $R_0 = 0.080\,\mu\text{m}$ ($80\,\text{nm}$ core), $R_1 = 0.125\,\mu\text{m}$ ($125\,\text{nm}$ inner shell), $R_2 = 0.1575\,\mu\text{m}$ ($157.5\,\text{nm}$ outer corona).
- **Hydrodynamic Diameter:** $2 R_2 = 0.315\,\mu\text{m} = 315\,\text{nm}$.
- **Compositional Strata:**
  1. Inner Core: Magnetic iron oxide core ($\text{Fe}_3\text{O}_4$), radius $80\,\text{nm}$, diffusivity $D_0 = 0.010\,\mu\text{m}^2/\text{s}$, initial concentration $C_0 = 0.035\,\text{mol/L}$.
  2. Middle Shell: Hydrophilic cross-linked PEGMA polymer matrix loaded with payload, thickness $45\,\text{nm}$, diffusivity $D_1 = 0.025\,\mu\text{m}^2/\text{s}$, initial concentration $C_1 = 0.015\,\text{mol/L}$.
  3. Outer Shell: Functionalized Vitamin B12 targeting corona, thickness $32.5\,\text{nm}$, diffusivity $D_2 = 0.048\,\mu\text{m}^2/\text{s}$, initial concentration $C_2 = 0.005\,\text{mol/L}$.
- **Boundary Properties:** Outer membrane permeability $P_m = 0.080\,\mu\text{m/s}$, microfluidic flow velocity $v_f = 15.0\,\text{mm/s}$.
- **Status:** `:predicted` concentration fields (`epistemic_status = :predicted`, `track = :track1_nanobio`).

### 3.2 Preset 2: `GhoshPatent_Cisplatin_DoubleShell_191nm`
- **Physical Architecture:** Concentric 3-stratum sphere ($L = 3$).
- **Radii:** $R_0 = 0.045\,\mu\text{m}$ ($45\,\text{nm}$ core), $R_1 = 0.075\,\mu\text{m}$ ($75\,\text{nm}$ drug layer), $R_2 = 0.0955\,\mu\text{m}$ ($95.5\,\text{nm}$ lipid gate).
- **Hydrodynamic Diameter:** $2 R_2 = 0.191\,\mu\text{m} = 191\,\text{nm}$.
- **Compositional Strata:**
  1. Inner Core: Superparamagnetic iron oxide core (SPION), radius $45\,\text{nm}$, diffusivity $D_0 = 0.005\,\mu\text{m}^2/\text{s}$, initial concentration $C_0 = 0.050\,\text{mol/L}$.
  2. Middle Shell: Cisplatin therapeutic matrix, thickness $30\,\text{nm}$, diffusivity $D_1 = 0.018\,\mu\text{m}^2/\text{s}$, initial concentration $C_1 = 0.020\,\text{mol/L}$.
  3. Outer Shell: Responsive lipid bilayer gating barrier, thickness $20.5\,\text{nm}$, diffusivity $D_2 = 0.038\,\mu\text{m}^2/\text{s}$, initial concentration $C_2 = 0.002\,\text{mol/L}$.
- **Boundary Properties:** Outer barrier permeability $P_m = 0.045\,\mu\text{m/s}$, microfluidic flow velocity $v_f = 12.0\,\text{mm/s}$.
- **Status:** `:predicted` concentration fields.

### 3.3 Dynamic Solver Functions
1. `fit_core_multishell_release_curve(times, cumulative_release; radii_um)`:
   - Recovers effective radial diffusivities $D_l$ and boundary permeability $P_m$ via nonlinear optimization against cumulative elution time-series.
   - Evaluates goodness-of-fit via $R^2 \ge 0.98$ and Root Mean Square Error $\text{RMSE} \le 0.025$.
2. `simulate_pulsed_duty_cycle_release(spec; duty_cycle, period_s, n_cycles, mode)`:
   - Compares instantaneous field-gated permeability modulation (step-function response) against thermal-lag relaxation ($\tau_{\text{thermal}} = 1.8\,\text{s}$).
   - Generates cumulative release curves, intra-stratum profiles, and channel exposure dynamics under pulsed magnetic actuation.

---

## 4. Discriminating Controls: Surface Association vs Intracellular Internalization

### 4.1 The Ambiguity Problem in Flow Cytometry
In single-cell flow cytometry, cellular fluorescence represents total integrated photon emissions from the interrogation volume:
$$I_{\text{total}} = I_{\text{internal}} + I_{\text{surface}}$$
A cell with 1,000 nanocarriers non-specifically adsorbed to its glycocalyx produces the identical fluorescence signature as a cell that has actively endocytosed 1,000 nanocarriers into acidic endosomes. Claiming high classification accuracy for `:nanocarrier_uptake` on unquenched samples is scientifically invalid because the classifier simply detects surface adhesion.

### 4.2 Mandatory Experimental Controls Protocol
To establish true internalization, Dr. Ghosh's lab and the computational pipeline require a four-tier discriminating control battery:

| Control Type | Method / Reagent | Mechanism | Expected Outcome |
|---|---|---|---|
| **1. Fluorescence Quenching** | Trypan blue ($0.04\%$ to $0.1\%$ w/v) | Membrane-impermeable diazo dye quenches extracellular green/fluorescein fluorophores via FRET / absorbance | Surface fluorescence extinguished ($>85\%$ reduction); internalized fluorescence protected inside intact cells |
| **2. Surface Stripping (Acid Wash)** | Ice-cold Glycine-HCl ($50\,\text{mM}$, $\text{pH } 2.5$) or Citrate buffer ($\text{pH } 4.0$) | Low pH disrupts non-covalent ligand-receptor bonds without membrane lysis | Strips $>90\%$ surface-adsorbed particles; post-wash signal isolates internalized fraction |
| **3. Temperature Block** | Incubation at $4^\circ\text{C}$ vs $37^\circ\text{C}$ | Energy depletion and membrane lipid freezing arrest active endocytosis at $4^\circ\text{C}$ while preserving passive binding | $4^\circ\text{C}$ signal represents purely surface binding; $[I(37^\circ\text{C}) - I(4^\circ\text{C})]$ isolates active internalization |
| **4. Confocal Optical Sectioning** | 3D z-stack confocal microscopy ($\Delta z \le 0.4\,\mu\text{m}$) + WGA membrane counter-stain | Direct spatial resolution of particle coordinates relative to cortical membrane | Orthogonal slices (x-z, y-z) and Manders colocalization coefficients prove cytosolic localization |
| **5. Pharmacological Inhibition** | Chlorpromazine ($10\,\mu\text{g/mL}$), Filipin III ($5\,\mu\text{g/mL}$), EIPA ($50\,\mu\text{M}$) | Selectively blocks clathrin-mediated, caveolae-mediated, or macropinocytosis pathways | Identifies specific biological internalization machinery in PC12 cells |

### 4.3 Quenching Protocol Details (Trypan Blue Assay)
1. Culture PC12 cells in complete RPMI-1640 supplemented with $10\%$ horse serum and $5\%$ fetal bovine serum.
2. Incubate cells with fluorophore-tagged nanocarriers (`Ghosh2010_B12_PEGMA_315nm` or `GhoshPatent_Cisplatin_DoubleShell_191nm`) at $37^\circ\text{C}$ for prescribed durations ($15\,\text{min}$, $1\,\text{h}$, $4\,\text{h}$, $24\,\text{h}$).
3. Prepare duplicate parallel wells for:
   - Unquenched total baseline ($I_{\text{total}}$).
   - Trypan blue quenched aliquot ($I_{\text{internal}}$).
   - Acid-washed stripped aliquot ($I_{\text{internal,strip}}$).
   - $4^\circ\text{C}$ temperature-blocked binding control ($I_{\text{surface,4C}}$).
4. For quenching: Add freshly prepared, filtered Trypan blue solution ($0.08\%$ final concentration in PBS, $\text{pH } 7.4$) directly to the cell suspension 60 seconds before flow-cytometric acquisition.
5. Record forward scatter (FSC), side scatter (SSC), primary fluorescence channel (e.g. FITC/FL1), and viability dye (e.g. DAPI/PI).
6. Calculate the True Internalization Ratio (TIR):
   $$\text{TIR} = \frac{I_{\text{quenched}} - I_{\text{autofluorescence}}}{I_{\text{unquenched}} - I_{\text{autofluorescence}}}$$
   Internalization is confirmed only when $\text{TIR} > 0.25$ and confocal orthogonal sectioning verifies cytoplasmic distribution.

---

## 5. Microfluidic Classification Bridge Architecture

The computational engine connects microfluidic transit physics with single-cell classification:
1. **Microfluidic Constriction Transit:**
   - Single cells pass through a tapered micropore constriction ($15\,\mu\text{m} \times 15\,\mu\text{m} \times 100\,\mu\text{m}$).
   - Measured electrical impedance yields transit duration $\Delta t_{\text{transit}}$, blockage ratio $\Delta I / I_0$, and deformability index.
   - High nanocarrier internalization modulates cell stiffness and transit profile.
2. **Supervised Classification Pipeline:**
   - Evaluates single cells across four target tasks: `:nanocarrier_uptake`, `:cell_stress_damage`, `:cell_type`, and `:micropore_transit_regime`.
   - Incorporates confidence thresholding with calibrated abstention (`:defer_for_review`).
   - Strictly enforces group-aware splitting by `:chip_id`, `:run_id`, and biological replicate to prevent test leakage.
3. **Empirical Gate G5 Validation Ladder:**
   - In accordance with Gate G5 requirements, all classifier models evaluated on synthetic FCS events remain tagged `software_verified = true`, but `experimentally_calibrated = false` and `empirically_validated = false`.
   - Transition to `empirically_validated = true` occurs only when Dr. Ghosh's lab supplies de-identified experimental FCS files acquired under the discriminating control protocol above.

---

## 6. Presentations and Collaborative Deliverables

1. **Exploratory Deck Update (`presentations/Single_Cell_Flow_Cytometry_Model_Bridge_Exploratory.pptx` and `.pdf`):**
   - Slides 1 to 5: High-dimensional cytometry architecture, microfluidic bridge, gating hierarchies, and 3D octant cutaway core-multishell visualization.
   - Backup Slide 6: Nanocarrier architecture comparison (`Ghosh2010_B12_PEGMA_315nm` vs `GhoshPatent_Cisplatin_DoubleShell_191nm` vs Biofilm aggregate).
   - Backup Slide 7: Core-multishell release curve fitting, parameter recovery ($D_l, P_m$), and residual analysis.
   - Backup Slide 8: Pulsed magnetic duty-cycle actuation and the PC12 surface binding vs internalization boundary.
2. **Interactive Browser Workbench:**
   - Shared 3D Wireframe-Over-Core visualizer in `workbench/microfluidic_cytometry_workbench.html` allowing real-time inspection of concentration profiles and pulsed release dynamics.
